Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
24.76
-0.77 (-3.02%)
At close: Jul 3, 2025, 1:00 PM
24.57
-0.19 (-0.77%)
After-hours: Jul 3, 2025, 4:58 PM EDT
Nektar Therapeutics Market Cap
Nektar Therapeutics has a market cap or net worth of $428.37 million as of July 3, 2025. Its market cap has increased by 99.43% in one year.
Market Cap
428.37M
Enterprise Value
394.38M
1-Year Change
99.43%
Ranking
Category
Stock Price
$24.76
Market Cap Chart
Since December 1, 1998, Nektar Therapeutics's market cap has decreased from $478.60M to $428.37M, a decrease of -10.49%. That is a compound annual growth rate of -0.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 307.20M | 79.13% |
| Dec 31, 2024 | 171.50M | 59.09% |
| Dec 29, 2023 | 107.80M | -74.62% |
| Dec 30, 2022 | 424.80M | -82.96% |
| Dec 31, 2021 | 2.49B | -18.24% |
| Dec 31, 2020 | 3.05B | -19.69% |
| Dec 31, 2019 | 3.80B | -33.26% |
| Dec 31, 2018 | 5.69B | -39.50% |
| Dec 29, 2017 | 9.40B | 401.47% |
| Dec 30, 2016 | 1.88B | -16.61% |
| Dec 31, 2015 | 2.25B | 12.95% |
| Dec 31, 2014 | 1.99B | 51.06% |
| Dec 31, 2013 | 1.32B | 54.43% |
| Dec 31, 2012 | 853.40M | 33.30% |
| Dec 30, 2011 | 640.20M | -47.19% |
| Dec 31, 2010 | 1.21B | 39.56% |
| Dec 31, 2009 | 868.60M | 68.99% |
| Dec 31, 2008 | 514.00M | -16.91% |
| Dec 31, 2007 | 618.60M | -54.96% |
| Dec 29, 2006 | 1.37B | -4.78% |
| Dec 30, 2005 | 1.44B | -15.13% |
| Dec 31, 2004 | 1.70B | 122.51% |
| Dec 31, 2003 | 763.80M | 70.57% |
| Dec 31, 2002 | 447.80M | -56.04% |
| Dec 31, 2001 | 1.02B | -55.42% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 309.43B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |